Portfolio company
Psylink
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops psychedelic therapies using engineered yeast to produce plant and fungi-derived compounds for patients with treatment-resistant mental health disorders.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Mindstate Design Labs
This biotechnology company develops custom psychedelic therapeutics using an artificial intelligence platform to treat mental health conditions for patients with various psychiatric disorders.
Compass Pathways
This biotechnology company develops psilocybin-based therapies for patients living with treatment-resistant depression and other mental health conditions.
Beckley Psytech
The company develops psychedelic-derived medicines to treat patients with neurological and psychiatric conditions such as treatment-resistant depression and rare headache disorders.
Gilgamesh
This clinical-stage biotechnology company develops novel psychedelic-related medicines and chemical entities to treat patients with depression and other neuropsychiatric disorders.
Psyon
This company provides psychedelic-assisted psychotherapy and psychiatric care to patients seeking treatment for mental health disorders.
CB Therapeutics
This company uses precision fermentation and yeast engineering to manufacture rare cannabinoids, tryptamines, and food proteins for the pharmaceutical, wellness, and food industries.
Small Pharma Limited
This clinical-stage biotechnology company develops psychedelic-based medicines and DMT therapies for patients with major depressive disorder and other mental health conditions.
ATAI
This biopharmaceutical company develops psychedelic-based treatments and mental health medicines for patients with neurological and psychiatric disorders, such as treatment-resistant depression and anxiety.
